Access restricted to students and staff of home institution
master's thesis
Hsp90 inhibitors as antitumor therapy

Marko Tomljanović (2015)
University of Zagreb
Faculty of Pharmacy and Biochemistry
Department of biochemistry and molecular biology
Cite this document

Tomljanović, M. (2015). Inhibitori Hsp90 kao antitumorska terapija (Master's thesis). Retrieved from https://urn.nsk.hr/urn:nbn:hr:163:815199

Tomljanović, Marko. "Inhibitori Hsp90 kao antitumorska terapija." Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, 2015. https://urn.nsk.hr/urn:nbn:hr:163:815199

Tomljanović, Marko. "Inhibitori Hsp90 kao antitumorska terapija." Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, 2015. https://urn.nsk.hr/urn:nbn:hr:163:815199

Tomljanović, M. (2015). 'Inhibitori Hsp90 kao antitumorska terapija', Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, accessed 17 October 2019, https://urn.nsk.hr/urn:nbn:hr:163:815199

Tomljanović M. Inhibitori Hsp90 kao antitumorska terapija [Master's thesis]. Zagreb: University of Zagreb, Faculty of Pharmacy and Biochemistry; 2015 [cited 2019 October 17] Available at: https://urn.nsk.hr/urn:nbn:hr:163:815199

M. Tomljanović, "Inhibitori Hsp90 kao antitumorska terapija", Master's thesis, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, 2015. Available at: https://urn.nsk.hr/urn:nbn:hr:163:815199